SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001628280-23-021546
Filing Date
2023-06-08
Accepted
2023-06-08 16:46:56
Documents
7
Effectiveness Date
2023-06-08

Document Format Files

Seq Description Document Type Size
1 S-8 vnda-20230608sx8.htm S-8 92899
2 EX-FILING FEES vnda-20230608sx8exhibit107.htm EX-FILING FEES 13832
3 EX-1.01 vnda-20230608sx8exhibit101.htm EX-1.01 221871
4 EX-5.1 vnda-20230608sx8exhibit51.htm EX-5.1 9330
5 EX-23.2 vnda-20230608sx8exhibit232.htm EX-23.2 2400
6 s8exhibit51image1.jpg GRAPHIC 27579
7 s8exhibit51image2.jpg GRAPHIC 66315
  Complete submission text file 0001628280-23-021546.txt   470870
Mailing Address 2200 PENNSYLVANIA AVE NW SUITE 300E WASHINGTON DC 20037
Business Address 2200 PENNSYLVANIA AVE NW SUITE 300E WASHINGTON DC 20037 202-734-3400
Vanda Pharmaceuticals Inc. (Filer) CIK: 0001347178 (see all company filings)

IRS No.: 030491827 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-272522 | Film No.: 231002599
SIC: 2834 Pharmaceutical Preparations